Tandem Diabetes Care, Inc. Share Price Today: Live Updates & Key Insights

Tandem Diabetes Care, Inc. share price today is $25.04, up 0.77%. The stock opened at $24.465 against the previous close of $24.63, with an intraday high of $24.95 and low of $24.

Tandem Diabetes Care, Inc. Share Price Chart

Tandem Diabetes Care, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Tandem Diabetes Care, Inc. Share Price Performance

$25.04 0.0077(0.77%) TNDM at 23 Mar 2026 03:31 PM Medical Devices
Lowest Today 24
Highest Today 24.95
Today’s Open 24.465
Prev. Close 24.63
52 Week High 29.65
52 Week Low 9.98
Day’s Range: Low 24 High 24.95
52-Week Range: Low 9.98 High 29.65
1 day return -
1 Week return +13.18
1 month return -12.27
3 month return +6.52
6 month return +90.11
1 year return +20.2
3 year return -40.1
5 year return -72.55
10 year return -

Tandem Diabetes Care, Inc. Institutional Holdings

BlackRock Inc 17.71

Vanguard Group Inc 10.74

Sessa Capital, L.P 7.32

iShares Core S&P Small-Cap ETF 6.03

ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 4.23

GW&K Investment Management, LLC 3.92

State Street Corp 3.91

Vanguard Total Stock Mkt Idx Inv 3.10

Citadel Advisors Llc 3.06

Paradice Investment Management LLC 3.04

Jennison Associates LLC 2.96

iShares Russell 2000 ETF 2.43

Jacobs Levy Equity Management, Inc. 2.42

Geode Capital Management, LLC 2.41

Driehaus Capital Management LLC 2.36

Vanguard Small Cap Index 2.25

UBS Group AG 2.20

Paradice Global Small Mid Cap Strategy 2.17

Freestone Grove Partners LP 2.11

The Goldman Sachs Group Inc 2.09

BNP Paribas Arbitrage, SA 1.83

Assenagon Asset Management SA 1.80

Two Sigma Investments LLC 1.76

Barclays PLC 1.74

Baillie Gifford & Co Limited. 1.68

Vanguard Explorer Inv 1.60

Vanguard Small Cap Growth Index Inv 1.25

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Fidelity Small Cap Index 0.97

State Street SPDR Port S&P 600 Sm CpETF 0.92

GW&K Small/Mid Cap Core CIT I 0.91

Jennison Health Sciences Equity 0.84

PGIM Jennison Health Sciences Z 0.84

iShares Russell 2000 Growth ETF 0.83

Vanguard VIF Small Co Gr 0.79

Meridian Growth Legacy 0.72

Strategic Advisers Fidelity US TtlStk 0.70

Heptagon Driehaus US Micro Cap Eq C$ Acc 0.69

Edinburgh Worldwide Ord 0.69

Vanguard Tax-Managed Small Cap Adm 0.67

Tandem Diabetes Care, Inc. Market Status

Strong Buy: 6

Buy: 4

Hold: 10

Sell: 1

Strong Sell: 0

Tandem Diabetes Care, Inc. Fundamentals

Market Cap 1695.85 M

PB Ratio 10.929

PE Ratio 0.0

Enterprise Value 1847.66 M

Total Assets 881.11 M

Volume 2424054

Tandem Diabetes Care, Inc. Company Financials

Annual Revenue FY25:1014736000 1014.7M, FY23:771423000 771.4M, FY22:801217000 801.2M, FY21:702799000 702.8M, FY20:498830000 498.8M

Annual Profit FY25:530847999 530.8M, FY23:null 0.0M, FY22:412986000 413.0M, FY21:376215000 376.2M, FY20:260520000 260.5M

Annual Net worth FY25:-204710000 -204.7M, FY23:-208462000 -208.5M, FY22:-94594000 -94.6M, FY21:15566000 15.6M, FY20:-34382000 -34.4M

Quarterly Revenue Q4/2025:290383000 290.4M, Q3/2025:249253000 249.3M, Q2/2025:240678000 240.7M, Q1/2025:234422000 234.4M, Q3/2024:363289000 363.3M

Quarterly Profit Q4/2025:167460000 167.5M, Q3/2025:134292000 134.3M, Q2/2025:125855000 125.9M, Q1/2025:118407000 118.4M, Q3/2024:124653000 124.7M

Quarterly Net worth Q4/2025:-589000 -0.6M, Q3/2025:-21165000 -21.2M, Q2/2025:-52400000 -52.4M, Q1/2025:-130556000 -130.6M, Q3/2024:-23251000 -23.3M

About Tandem Diabetes Care, Inc. & investment objective

Company Information Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Organisation Medical Devices

Employees 2500

Industry Medical Devices

CEO Mr. John F. Sheridan

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Tandem Diabetes Care, Inc. FAQs

What is the share price of Tandem Diabetes Care, Inc. today?

The current share price of Tandem Diabetes Care, Inc. is $25.04.

Can I buy Tandem Diabetes Care, Inc. shares in India?

Yes, Indian investors can buy Tandem Diabetes Care, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Tandem Diabetes Care, Inc. shares in India?

You can easily invest in Tandem Diabetes Care, Inc. shares from India by:

Can I buy fractional shares of Tandem Diabetes Care, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. has a market cap of $1695.85 M.

In which sector does Tandem Diabetes Care, Inc. belong?

Tandem Diabetes Care, Inc. operates in the Medical Devices sector.

What documents are required to invest in Tandem Diabetes Care, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Tandem Diabetes Care, Inc.?

The PE ratio of Tandem Diabetes Care, Inc. is N/A and the PB ratio is 10.93.